Shionogi & Co., Ltd. (TYO:4507)
Japan
· Delayed Price · Currency is JPY 2,755.00
+36.50 (1.34%)
Jun 26, 2026, 3:30 PM JST
Shionogi & Employees
Shionogi & had 6,223 employees as of March 31, 2026. The number of employees increased by 1,268 or 25.59% compared to the previous year.
Employees
6,223
Change (1Y)
1,268
Growth (1Y)
25.59%
Revenue / Employee
80.30M JPY
Profits / Employee
32.97M JPY
Market Cap
2,344.44B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Eisai | 10,543 |
| Takeda Pharmaceutical Company | 47,029 |
| Sumitomo Pharma | 3,832 |
| Tsumura & Co. | 4,272 |
| Nippon Shinyaku | 2,243 |
| Toho Holdings | 7,609 |
| Sawai Group Holdings | 3,310 |
| Towa Pharmaceutical | 4,788 |
Shionogi & News
- 4 days ago - Shionogi & Slides: Investor presentation - Filings
- 26 days ago - Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure - Business Wire
- 27 days ago - US regulator approves oral drug from Japan's Shionogi to prevent COVID-19 - Reuters
- 6 weeks ago - New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure - Business Wire
- 6 weeks ago - Shionogi & Quarterly report: Q4 2026 - Filings
- 6 weeks ago - Shionogi & Slides: Q4 2026 - Filings
- 2 months ago - Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats - Business Wire
- 3 months ago - Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone) - Business Wire